PATENT CLAIM ANALYSIS

Application Number: 16325837
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "421000"]

Abstract:
The present invention relates to polymorphic forms of marizomib (e.g., Morphic Form I). The morphic forms can be used alone and in pharmaceutical compositions for the treatment of disease.

Claim (Index 1):
Morphic Form I of marizomib, characterized by an X-ray powder diffraction pattern including peaks at about 7.2, 14.5, and 36.7\u00b0 2\u03b8 using Cu K\u03b1 radiation.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.13333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15373874', '16135171', '15828935', '15946899', '13800374']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7525928824962131
- 35 USC 102 Novelty (BERT): 0.5103295947574774
- Combined Prediction Score: 0.7283665537223396
- Mean Citation Score: 250.95537600000003
- Max Citation Score: 254.65173
- Similarity Product: 183.592411268692

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test